NON-STEREOSPECIFIC, NONTRIPLET CYCLOPROPANATIONS WITH DIBROMOMETHYLENE

被引:9
|
作者
LAMBERT, JB
LARSON, EG
BOSCH, RJ
机构
关键词
D O I
10.1016/S0040-4039(00)94278-3
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
引用
下载
收藏
页码:3799 / 3802
页数:4
相关论文
共 50 条
  • [1] A NON-STEREOSPECIFIC SYNTHESIS OF (+/-)-DAVANONE
    BIRCH, AJ
    CORRIE, JET
    RAO, GSR
    AUSTRALIAN JOURNAL OF CHEMISTRY, 1970, 23 (09) : 1811 - &
  • [2] Bioequivalence of chiral drugs - Stereospecific versus non-stereospecific methods
    Mehvar, R
    Jamali, F
    CLINICAL PHARMACOKINETICS, 1997, 33 (02) : 122 - 141
  • [3] NON-STEREOSPECIFIC RING EXPANSIONS OF BENZOTHIAZOLINE SULFOXIDES
    HORI, M
    KATAOKA, T
    SHIMIZU, H
    UEDA, N
    TETRAHEDRON LETTERS, 1981, 22 (18) : 1701 - 1704
  • [4] A HIGHLY NON-STEREOSPECIFIC CATALYST FOR PROPENE POLYMERIZATION
    SHIONO, T
    UCHINO, H
    SOGA, K
    POLYMER BULLETIN, 1989, 21 (01) : 19 - 21
  • [5] A review on non-stereospecific haloalkanoic acid dehalogenases
    Hamid, Tengku Haziyamin Tengku Abdul
    Hamid, Azzmer Azzar Abdul
    Huyop, Fahrul
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (48): : 9725 - 9736
  • [6] Non-stereospecific Reductive Cleavage of 2-Isoxazolines
    E. V. Koroleva
    Ya. M. Katok
    F. A. Lakhvich
    Chemistry of Heterocyclic Compounds, 2003, 39 (6) : 780 - 783
  • [7] STEREOSPECIFIC AND NON-STEREOSPECIFIC EFFECTS OF (+)-MORPHINE AND (-)-MORPHINE - EVIDENCE FOR A NEW CLASS OF RECEPTORS
    JACQUET, YF
    KLEE, WA
    RICE, KC
    IIJIMA, I
    MINAMIKAWA, J
    SCIENCE, 1977, 198 (4319) : 842 - 845
  • [8] NON-STEREOSPECIFIC SUBSTRATE USAGE BY GLYOXALASE-I
    GRIFFIS, CEF
    ONG, LH
    BUETTNER, L
    CREIGHTON, DJ
    BIOCHEMISTRY, 1983, 22 (12) : 2945 - 2951
  • [9] NON-STEREOSPECIFIC RING EXPANSION REACTIONS OF BENZOTHIAZOLINE SULFOXIDES
    SHIMIZU, H
    UEDA, N
    KATAOKA, T
    HORI, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1984, 32 (07) : 2571 - 2590
  • [10] Bioequivalence of Chiral DrugsStereospecific versus Non-Stereospecific Methods
    Reza Mehvar
    Fakhreddin Jamali
    Clinical Pharmacokinetics, 1997, 33 : 122 - 141